Clinical trial
Safety and Efficacy Study of Erythropoietin as add-on Therapy of…
NCT00355095 · Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH, Other · Completed
Key facts
| NCT number | NCT00355095 |
|---|---|
| Title | Safety and Efficacy Study of Erythropoietin as add-on Therapy of Methylprednisolone to Treat Acute Optic Neuritis |
| Official title | Double Blind, Placebo-controlled Study to Determine the Safety and Efficacy of Erythropoietin as an add-on Therapy of Methylprednisolone in Subjects With Acute Optic Neuritis (VISION PROTECT) |
| Lead sponsor | Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Optic Neuritis |
| Intervention type | Drug |
| Interventions | Erythropoietin |
| Enrollment | 40 |
| Start date | Aug 1, 2006 |
| Primary completion | Feb 1, 2011 |
| Completion | Jul 1, 2011 |
| First posted | Jul 21, 2006 |
| Last update posted | Sep 13, 2012 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: